未登录

P

Prabuddha Waduge

baylor college of medicine

H指数:9

被引数:212

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice

IF3.9

2023-07-065

OAAI

Profiling disease-selective drug targets: From proteomics to ligandomics

DRUG DISCOVERY TODAY

IF7.5

2023-03-015

OAAI

Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization

IF4.2

2022-02-018

OA

Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy

分泌素III严格调节氧诱导的视网膜病变中的病理性而非生理性血管生成

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2022-01-1016

OA

Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization

选择性靶向疾病限制性分泌素III减轻脉络膜新生血管

IF4.2

2021-12-1712

OA

An Advanced Apralog with Increased in vitro and in vivo Activity toward Gram-negative Pathogens and Reduced ex vivo Cochleotoxicity

IF3.4

2020-10-2322

OAAI

Use of a fluorescence assay to determine relative affinities of semisynthetic aminoglycosides to small RNAs representing bacterial and mitochondrial A sites

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-11-015

OAAI

Chemical probing for examining the structure of modified RNAs and ligand binding to RNA

IF4.3

2019-03-0115

OAAI

Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2019-02-2252

OAAI